Medical experts and politicians question who will be chosen as the CDC’s next leader amid a surge in measles cases and ...

President Donald Trump is scheduled Thursday to welcome NATO Secretary General Mark Rutte to the White House. The pair are ...

Israelis and others say the allegations are baseless and slanderous, and issued by a group with a long history of bias against the Jewish state and outright antisemitism. The decision by the ...

Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs).

After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and development, particularly in clinical trials. The good news is that ...